Cargando…

The effect of hemodialysis on ocular changes in patients with the end-stage renal disease

Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Guijiang, Hao, Rui, Zhang, Longli, Shi, Xueying, Hei, Kaiwen, Dong, Lijie, Wei, Fang, Jiang, Aili, Li, Bo, Li, Xiaorong, Ke, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609354/
https://www.ncbi.nlm.nih.gov/pubmed/31269848
http://dx.doi.org/10.1080/0886022X.2019.1635494
_version_ 1783432299685085184
author Sun, Guijiang
Hao, Rui
Zhang, Longli
Shi, Xueying
Hei, Kaiwen
Dong, Lijie
Wei, Fang
Jiang, Aili
Li, Bo
Li, Xiaorong
Ke, Yifeng
author_facet Sun, Guijiang
Hao, Rui
Zhang, Longli
Shi, Xueying
Hei, Kaiwen
Dong, Lijie
Wei, Fang
Jiang, Aili
Li, Bo
Li, Xiaorong
Ke, Yifeng
author_sort Sun, Guijiang
collection PubMed
description Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects of ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), retinal arteriolar caliber (RAC), retinal venular calibre (RVC), in ESRD patients following hemodialysis. Materials and methods: Two-hundred and two ESRD patients were recruited resulting in 404 eyes evaluations. All patients underwent hemodialysis in the Dialysis Unit of the Second Hospital of Tianjin Medical University. BCVA, CMT, IOP, SFCT, RAC and RVC were evaluated before and after hemodialysis. Systemic parameters were collected such as age, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of hemodialysis, body weight changes, high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), very low density lipoprotein cholesterol (VLDLC), glycosylated hemoglobin (HbA1c). Results: The causes of ESRD patients included chronic glomerulonephritis (n = 65), diabetes mellitus (n = 60), hypertensive nephrosclerosis (n = 37), and other causes (n = 40). In our study, BCVA (p = .817), CMT (p = .252) and IOP (p = .978) did not significantly change after hemodialysis. SFCT significantly decreased from 254.29 ± 69.36 μm to 235.54 ± 659.90 μm (p = .002) following hemodialysis. SFCT changes were significantly correlated with SBP (p = .042) and body weight changes (p = .044). The RAC and RVC were dilated significantly (p = .033, p = .007). RVC changes were correlated with baseline DBP (p = .003), HDLC (p = .009), LDLC (p = .004) and changes in DBP (p = .037) and body weight (p = .001). Conclusion: Hemodialysis can affect various ocular parameters including SFCT, RAC and RVC, which changed significantly following hemodialysis. Whereas BCVA, IOP and CMT did not change after hemodialysis in ESRD patients. The systemic compensatory mechanisms of the changes in SBP, DBP, body weight following hemodialysis need further study.
format Online
Article
Text
id pubmed-6609354
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-66093542019-07-12 The effect of hemodialysis on ocular changes in patients with the end-stage renal disease Sun, Guijiang Hao, Rui Zhang, Longli Shi, Xueying Hei, Kaiwen Dong, Lijie Wei, Fang Jiang, Aili Li, Bo Li, Xiaorong Ke, Yifeng Ren Fail Clinical Study Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects of ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), retinal arteriolar caliber (RAC), retinal venular calibre (RVC), in ESRD patients following hemodialysis. Materials and methods: Two-hundred and two ESRD patients were recruited resulting in 404 eyes evaluations. All patients underwent hemodialysis in the Dialysis Unit of the Second Hospital of Tianjin Medical University. BCVA, CMT, IOP, SFCT, RAC and RVC were evaluated before and after hemodialysis. Systemic parameters were collected such as age, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of hemodialysis, body weight changes, high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), very low density lipoprotein cholesterol (VLDLC), glycosylated hemoglobin (HbA1c). Results: The causes of ESRD patients included chronic glomerulonephritis (n = 65), diabetes mellitus (n = 60), hypertensive nephrosclerosis (n = 37), and other causes (n = 40). In our study, BCVA (p = .817), CMT (p = .252) and IOP (p = .978) did not significantly change after hemodialysis. SFCT significantly decreased from 254.29 ± 69.36 μm to 235.54 ± 659.90 μm (p = .002) following hemodialysis. SFCT changes were significantly correlated with SBP (p = .042) and body weight changes (p = .044). The RAC and RVC were dilated significantly (p = .033, p = .007). RVC changes were correlated with baseline DBP (p = .003), HDLC (p = .009), LDLC (p = .004) and changes in DBP (p = .037) and body weight (p = .001). Conclusion: Hemodialysis can affect various ocular parameters including SFCT, RAC and RVC, which changed significantly following hemodialysis. Whereas BCVA, IOP and CMT did not change after hemodialysis in ESRD patients. The systemic compensatory mechanisms of the changes in SBP, DBP, body weight following hemodialysis need further study. Taylor & Francis 2019-07-04 /pmc/articles/PMC6609354/ /pubmed/31269848 http://dx.doi.org/10.1080/0886022X.2019.1635494 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Sun, Guijiang
Hao, Rui
Zhang, Longli
Shi, Xueying
Hei, Kaiwen
Dong, Lijie
Wei, Fang
Jiang, Aili
Li, Bo
Li, Xiaorong
Ke, Yifeng
The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title_full The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title_fullStr The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title_full_unstemmed The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title_short The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
title_sort effect of hemodialysis on ocular changes in patients with the end-stage renal disease
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609354/
https://www.ncbi.nlm.nih.gov/pubmed/31269848
http://dx.doi.org/10.1080/0886022X.2019.1635494
work_keys_str_mv AT sunguijiang theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT haorui theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT zhanglongli theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT shixueying theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT heikaiwen theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT donglijie theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT weifang theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT jiangaili theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT libo theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT lixiaorong theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT keyifeng theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT sunguijiang effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT haorui effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT zhanglongli effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT shixueying effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT heikaiwen effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT donglijie effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT weifang effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT jiangaili effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT libo effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT lixiaorong effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease
AT keyifeng effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease